122193-68-4 | 3-[2-(Perfluorohexyl)ethoxy]-1,2-epoxypropane

CAS:122193-68-4 | 3-[2-(Perfluorohexyl)ethoxy]-1,2-epoxypropane ,Description

3-[2-(Perfluorohexyl)ethoxy]-1,2-epoxypropane, commonly referred to as PFHxEP, is a fluorinated ether compound that has been studied extensively in the past decade due to its unique properties. PFHxEP is a cyclic ether that is composed of a six-membered ring containing two fluorine atoms, two oxygen atoms and two carbon atoms. It is a colorless, volatile liquid with a boiling point of 134°C and a melting point of -83°C. PFHxEP has a variety of applications in scientific research due to its unique properties, such as its low surface tension, low vapor pressure, and high thermal stability.
 

Scientific Research Applications

• Synthesis of Ring-Closed Products: It is used in synthesizing ring-closed products like 1,4-dioxanone, 1,4-oxathianone, and 1,4-dithianone compounds (Kawa, Hamouda, & Ishikawa, 1980).
• Synthesis of α,β-Unsaturated Aldehydes: It plays a role in the syntheses of α,β-unsaturated aldehydes (Wada, Nakamura, Taguchi, & Takei, 1977) .
• Chiral Analysis: Useful in converting enantiomers into distinct diastereomers through non-covalently bound complexes (Leung, Marshall, & Stuart, 2020).
• Enhancement in Li-air Batteries: Significantly enhances the discharge capacity of Li-air batteries, making them comparable to state-of-the-art Li-ion batteries (Wan et al., 2017) .
• Pharmaceutical Applications: It's an important intermediate in the cardiovascular disease medicine propranolol (Zha Xiao-lin, 2005) .
• Preparation of Benzoheterocyclic Compounds: Used for preparing new benzoheterocyclic compounds containing CF3 and C2F5 (Ishikawa & Sasaki, 1977).
• Polymerization Studies: Involved in the ring-opening polymerization with organozinc compounds, producing regioregular, head-to-tail poly(TFEP) (Umezawa et al., 1994).
• Biocatalyst in Enantiopure Epoxide Production: JS614 strain is a new biocatalyst for enantiopure epoxide production, relevant in pharmaceutical synthesis (Owens, Karceski, & Mattes, 2009).

More Information